JDRF recently posted two new opportunities. The first is titled Overcoming Obstacles to Achieving Immune Tolerance in Type 1 Diabetes. From JDRF: “JDRF is soliciting letters of intent for the identification of key barriers in the way of therapeutically restoring immune tolerance in type 1 diabetes…
From JDRF: Purpose: JDRF is soliciting letters of intent (LOI) for the discovery, development and pre-clinical testing of tolerogenic delivery systems (TDS) of diabetes-specific autoantigens designed to prevent and/or reverse type 1 diabetes (T1D). JDRF is committed to translation of research findings towards clinical results and is most…
JDRF and the American Diabetes Association, announced today that a new classification approach for staging T1D in its earliest presymptomatic stages would be published in the September 24th online version of Diabetes Care.
“In less than a decade, nPOD has provided more than 140 research teams with tissues for T1D-related research and grown from 6 collaborating labs to 168 in 17 countries.”…
The UF Diabetes Center of Excellence gives parents a crash course on taking care of a child with diabetes with doctors keeping close tabs on their patients between appointments. Meet one of our special patients, Sydney Thomas, and learn about the ways the DCOE can assist you.
Did you hear the great news about the first artificial pancreas outpatient trial in the U.S. being approved by the FDA? To help ensure that progress like the artificial pancreas continues to improve the lives of those with diabetes by simply sending an email to your members of Congress.
The JDRF Walk to Cure Diabetes draws people together in a healthy activity for a worthy cause, raising money to improve the lives of every person affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing T1D. It's fun for families and builds camaraderie among company employees. Above all, it's an event you will feel good about being a part of.
Join us for a meet and greet with Ryan Reed before he makes his ARCA Racing Series debut at Daytona Int’l Speedway. This event will occur on Sunday, February 12th from 12-4p.m. All proceeds benefits JDRF.
25.8 million men, women, and children in the United States have diabetes. That is 8.3% of the American population. 79 million more Americans are currently at risk for type 2 diabetes.
Last week JDRF launched the Artificial Pancreas Campaign. Now, they need your help. You can help the FDA understand what having access to the Artificial Pancreas will mean to those living with diabetes by signing a petition. The goal of the initiative is to convince the FDA to adopt the recommendations of clinical experts to advance the development of an artificial pancreas, a device which has the potential to be the most revolutionary advancement in the treatment of T1D since the discovery of insulin.
